相关实验视频
Updated: Jul 23, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
201
在非洲的风湿病学中生物类似药的潜力
Mohamed Hassan Abu-Zaid1, Adewale Adebajo2,3, Yasser El Miedany4,5
1Rheumatology and Rehabilitation, Tanta University Faculty of Medicine, Tanta, Egypt drmhassan113@yahoo.com.
Annals of the rheumatic diseases
|July 19, 2023
概括
生物类似药物为非洲风湿病患者提供了扩大生物药物获取机会. 在监管批准和可用性方面仍然存在挑战,但正在努力增加它们的使用.
科学领域:
- 类风湿病学 类风湿病学
- 药物经济学 药物经济学
- 非洲卫生系统 非洲卫生系统
背景情况:
- 生物类药物与参考生物制品 (RBPs) 非常相似.
- 在许多非洲国家,生物类似药的监管框架尚不发达.
- 在非洲,对于风湿性疾病的生物类似药的可用性有限.
研究的目的:
- 探索生物类似药在非洲风湿病学中的潜在益处.
- 确定阻碍该地区采用生物类似药物的挑战.
- 突出目前的倡议,促进生物类似药的可用性和使用.
主要方法:
- 这是一篇社论,而不是一项初级研究.
- 它综合了非洲生物类似药的现有知识和专家意见.
- 专注于类风湿性疾病的背景.
主要成果:
- 生物类药物为增加非洲风湿病患者获得生物治疗的机会提供了重大机会.
- 关键的挑战包括不断变化的监管环境和有限的市场存在.
- 正在进行的努力旨在克服这些障碍.
结论:
- 在非洲扩大生物类似药的使用可以通过提高患者获得先进的生物疗法来改善类风湿病的护理.
- 解决监管障碍和促进市场发展对于实现这些好处至关重要.
- 需要共同努力,以促进生物类似药物融入非洲医疗保健系统.
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Rheumatic Heart Disease I: Introduction
17
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17
Rheumatic Heart Disease III: Medical Management
20
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
20
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
174
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
174
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K

